1. RPN2 in cancer: An overview
    Zhengxuan Han et al, 2023, Gene CrossRef
  2. Small Interfering RNA-Mediated Silencing of the Ribophorin II Gene: Advances in the Treatment of Malignant Breast Cancer
    Ryou-u Takahashi et al, 2019, Nucleic Acid Nanotheranostics CrossRef
  3. RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer
    Daisuke Fujimoto et al, 2018, Oncotarget CrossRef
  4. Capsaicin Potentiates Anticancer Drug Efficacy Through Autophagy-Mediated Ribophorin II Downregulation and Necroptosis in Oral Squamous Cell Carcinoma Cells
    Yi-Ching Huang et al, 2021, Frontiers in Pharmacology CrossRef
  5. Expression of α-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity
    SUMEI LU et al, 2016, Oncology Reports CrossRef
  6. RPN2 promotes colorectal cancer cell proliferation through modulating the glycosylation status of EGFR
    Haiping Li et al, 2017, Oncotarget CrossRef
  7. Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review
    Leonardo de Oliveira Siquara da Rocha et al, 2024, Biology CrossRef
  8. RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
    Wangyang Zheng et al, 2022, Journal of Oncology CrossRef
  9. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer
    Hongzhi Zhang et al, 2019, International Journal of Biological Macromolecules CrossRef
  10. Overexpression of RPN2 suppresses radiosensitivity of glioma cells by activating STAT3 signal transduction
    Changyu Li et al, 2020, Molecular Medicine CrossRef
  11. Overexpression of ribophorin II is required for viability of nasopharyngeal cancer cells by regulating JAK1/STAT3 activation
    Bin Wang et al, 2021, Immunopharmacology and Immunotoxicology CrossRef
  12. Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapy
    Peihong Qiu et al, 2017, European Journal of Medicinal Chemistry CrossRef